Dropbox Inc vs Sanofi SA — how do they compare? Dropbox Inc trades at $33.8 (market cap $7.41B), while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 14.1× Dropbox Inc's market cap, and Sanofi SA pays a 5.55% dividend while Dropbox Inc pays none. Which is the better fit depends on your goals.
| DBX | SNY | |
|---|---|---|
Market Cap | $7.41B | $104.30B |
Sector | Technology | Health |
52-Week High | $35.00 | $52.34 |
52-Week Low | $22.06 | $41.33 |
Enterprise Value | $10.27B | $124.19B |
Dividend Yield | — | 5.55% |
Trailing returns across standard periods
Latest headlines on both assets
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →